Research group - Anders Sönnerborg
Translational research on chronic viral infections with focus on HIV and hepatitis C.
The research of our group is translational, studying HIV-1 and hepatitis pathogenesis, treatment (cure, resistance) and molecular epidemiology from both an experimental and a translational point of view. The consequences of the damage to the gut-blood barrier are studied as well as mechanisms for viral latency. The group collaborates intensively with national and international partners. The infrastructure of the translational research is the HIV cohort at Karolinska University Hospital and the national InfCare HIV database. Global collaborations are focused on aspects on HIV treatment, including drug resistance, and molecular epidemiology. They are performed together with partners from Europe and several low-middle income countries (Ethiopia, Tanzania, Kenya, India, Bangladesh and Vietnam).
Research group leader Anders Sönnerborg
|Emmi Andersson||Graduate Student|
|Abu Bakar Siddik||Associated|
|Nigus Fikrie Telele||Research assistant on study grant|
|Shambhu Prasad Ganeshappa Aralaguppe||Graduate Student|
|Birgitta Lesko||Graduate Student|
|Ujjwal Neogi||Assistant professor|
|Duncan Njenda||PhD student|
|Kajsa Noyan||PhD student|
|Anders Sönnerborg||Professor/senior physician|
|Amare Worku Kalu||Research assistant on study grant|
|Johanna Brännström||PhD student, MD|
|Tina Carlander||PhD student, MD|
|Piotr Nowak||Senior researcher, MD, PhD|
|Veronica Svedhem||Senior researcher, MD, PhD|
|Jan Vesterbacka||PhD student|
- Molecular biology
- Cell cultures
Swedish Research Council, EU FP7, Swedish International Developing Agency, Swedish Civil Contingencies Agency, Stockholm County Council, Swedish Physicians Against AIDS Foundation, Swedish Association of Local Authorities and Regions, Ruth and Richard Julin Foundation, Sixten Gemzéus Stiftelse/Gålöstiftelsen, Gilead Sciences, AbbVie.
Lectures and tutoring in Clinical Microbiology under the curriculum of the Biomedical Laboratory Science Programme.
Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort.
BMC Infect. Dis. 2013 Nov;13():537
Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.
PLoS ONE 2013 ;8(3):e59337
Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection.
Int J Microbiol 2012 ;2012():263836